AG
AMGN icon

Artal Group’s Amgen AMGN Stock Holding History

Artal Group’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-100,000
Closed -$17.4M – 112
2017
Q4 		$17.4M Hold
100,000
– – 0.26% 34
2017
Q3 		$18.6M Buy
+100,000
New +$17.7M 0.32% 23
2014
Q3 		– Sell
-400,000
Closed -$47.3M – 87
2014
Q2 		$47.3M Buy
400,000
+300,000
+300% +$34.7M 1.91% 6
2014
Q1 		$12.3M Hold
100,000
– – 0.45% 49
2013
Q4 		$11.4M Sell
100,000
-100,000
-50% -$11.4M 0.41% 42
2013
Q3 		$22.4M Buy
200,000
+150,000
+300% +$16.3M 0.73% 22
2013
Q2 		$4.93M Buy
+50,000
New +$5.19M 0.16% 70

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Artal Group's AMGN Position: Q2 2014 in Review

Artal Group sold out of Amgen (AMGN) in Q2 2014, closing a stake of 150,000 shares — an estimated $17.4M sold.

Artal Group first reported a position in AMGN in Q2 2013 and held it in 4 quarters. The position peaked at $18.5M in Q1 2014. 1,185 funds tracked by Wall St. Rank hold AMGN as of Q2 2014.

  • Artal Group reported no remaining Amgen position as of Q2 2014 after selling out during the quarter.
  • Artal Group sold 150,000 Amgen shares in Q2 2014, an estimated $17.4M.
  • Artal Group first reported a position in Amgen in Q2 2013 and held it in 4 quarters.
  • Artal Group's Amgen position peaked at $18.5M in Q1 2014.
  • 1,185 funds tracked by Wall St. Rank held Amgen as of Q2 2014.

Based on Artal Group's 13F filing for Q2 2014, filed 14 Aug 2014.